佰仁医疗收盘下跌1.54%，滚动市盈率98.10倍，总市值167.27亿元

Core Viewpoint - The company Baijun Medical has a high rolling price-to-earnings (PE) ratio of 98.10, significantly above the industry average of 59.49, indicating potential overvaluation in the medical device sector [1][2] Company Summary - Baijun Medical's closing stock price on August 19 was 121.43 yuan, down 1.54%, with a total market capitalization of 16.727 billion yuan [1] - The company specializes in the research, production, sales, and service of medical devices, with key products including various types of biological patches and heart valve systems [1] - As of March 31, 2025, the number of shareholders increased to 3,099, with an average holding value of 352,800 yuan and an average shareholding of 27,600 shares [1] - The latest quarterly report for Q1 2025 shows revenue of 100 million yuan, a year-on-year increase of 31.30%, and a net profit of 32.5043 million yuan, up 290.69%, with a gross profit margin of 85.72% [1] Industry Summary - The average PE ratio for the medical device industry is 59.49, with a median of 40.19, positioning Baijun Medical at 104th in the industry ranking [2] - Other companies in the industry have significantly lower PE ratios, with the lowest being 11.65 for Jiuan Medical and the highest being 20.67 for Antu Biology [2]